A large case-control study by RIKEN in Japan has found that people who carry certain genetic risk factors for gastric (stomach) cancer have a much greater risk if they have also been infected by the bacterium Helicobacter pylori. The study could contribute to the development of tailored genomic medicine for treating stomach cancer.